Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

COVID-19 vaccines had more side effects and worse perception than flu vaccines in Korean lupus patients.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Malnutrition can cause unusual eyelash growth and hair loss.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

A person was born with both a rare hairless condition and a type of birthmark, which is an uncommon combination.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

COVID-19 vaccination may trigger lupus in some people.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

A genetic variant linked to hair thinning in Japanese women was found.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

The document concludes that various disorders can cause hair loss in dogs, each requiring different treatments, and some may heal on their own.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Lower LDL-c levels predict higher COVID-19 mortality.